Blood cancer Clinical Trials in Hackensack, NJ
As of June 2026, 43 paid clinical trials are recruiting for Blood cancer in Hackensack, New Jersey. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
43 clinical trials for Blood cancer
·Clear filters·↓ Download CSVTrial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Study of SGR-1505 in Mature B-Cell Neoplasms
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Long-Term Follow-up Study
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
About research studies in Hackensack
Hackensack has approximately 332 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Hackensack
Researchers run research studies in Hackensack, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hackensack University Medical Center | Neuroblastoma, Advanced Solid Tumor, Heart Failure | 135 |
| John Theurer Cancer Center at Hackensack University Medical Center | Leukemia, Myeloid, Acute, Acute Myeloid Leukemia, Advanced Solid Tumors | 42 |
| John Theurer Cancer Center | Melanoma, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer | 16 |
| Hackensack Meridian Health | Acute Myocardial Infarction (AMI), Atrial Fibrillation, Breast Cancer | 11 |
| Northeast Regional Epilepsy Group | Dravet Syndrome, Focal Onset Seizures, KCNT1-Related Epilepsy | 8 |
| John Theurer Cancer Center at Hackensack UMC | Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Lung Cancer | 7 |
| John Theurer Cancer Center Hackensack University Medical Center | Advanced Solid Tumor, Advanced Solid Tumors, Chronic Lymphocytic Leukemia | 6 |
| Hackensack Meridian Health (Data collection only) | Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma, High Grade B Cell Lymphoma | 4 |
| Hackensack Meridian Health - Hackensack University Medical Center | Plasma Cell Myeloma Refractory, Hemophilia, Glycogen Storage Disease Type II | 4 |
| NEREG | Focal Epilepsy | 3 |
| Praxis Research Site | Developmental and Epileptic Encephalopathy 1, Focal Onset Seizure, Focal Seizure | 3 |
| HMH Hackensack University Medical Center | Clostridioides Difficile Associated Disease, Stroke, Acute | 2 |
| Hackensack Medical Center | Acute Myeloid Leukemia, Alzheimer Disease, Chronic Myelomonocytic Leukemia | 2 |
| Hackensack Univeristy Medical Center | Pre-Term, Premature, Respiratory Distress Syndrome in Premature Infant | 2 |
| Hackensack University Medical Center - John Theurer Cancer Center | Endometrial Cancer, Non-squamous EGFR Wt NSCLC, Ovarian Cancer | 2 |
| John Theurer Cancer Center-Hackensack | Locally Advanced Extrapulmonary Neuroendocrine Carcinoma, Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung, Locally Advanced Merkel Cell Carcinoma | 2 |
| Joseph M. Sanzari Children's Hospital | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 2 |
| Investigative | Solid Tumors, Hidradenitis Suppurativa (HS) | 2 |
| Amanda Khoudary | Lung Cancer | 1 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Clinical Trial Site | Cerebral Amyloid Angiopathy | 1 |
| Context Investigational Site | Cholangiocarcinoma Advanced, Cholangiocarcinoma Non-resectable, Colorectal Cancer | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 1 |
| GSK Investigational Site | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 1 |
| Gastroenterology Associates of New Jersey | Colo-rectal Cancer | 1 |
Active & Upcoming Studies in Hackensack (2026)
Recruiting trials in Hackensack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (183 active studies)
- Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma · Phase 2 · Rapa Therapeutics LLC
- A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients · Phase 2 · Georgetown University
Neurology & pain (15 active studies)
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric Participants With KCNT1-related Epilepsy · Phase 2 · Actio Biosciences, Inc.
- Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe · Santiago Ortega Gutierrez
Cardiovascular (15 active studies)
- Pivotal Trial to Evaluate the Safety and Effectiveness of the P&F TricValve® Transcatheter Bicaval Valve System · P+F Products + Features USA Inc.
- CCM OPEN HF Registry · Impulse Dynamics
Pediatric (4 active studies)
- Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration · Hackensack Meridian Health
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
Mental health & behavior (1 active study)
- OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression · Hackensack Meridian Health
Diabetes & metabolic (1 active study)
- A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma · Phase 2 · Children's Oncology Group
Common conditions studied in Hackensack
- Advanced Solid Tumor (11 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (10 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Advanced Solid Tumors (9 active studies). Recruiting Advanced Solid Tumors studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (9 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (9 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (8 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
Leading research sponsors in Hackensack
- Merck Sharp & Dohme LLC
- Children's Oncology Group
- Hackensack Meridian Health
- AstraZeneca
- National Cancer Institute (NCI)
Local regulations and guidelines
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Hackensack. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Hackensack
Hipa.ai aggregates every recruiting study in Hackensack from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Hackensack?
There are approximately 332 recruiting clinical trials in Hackensack, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hackensack pay participants?
Most recruiting trials in Hackensack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hackensack?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hackensack?
The most common conditions under active study in Hackensack include Advanced Solid Tumor (11), Acute Myeloid Leukemia (10), Advanced Solid Tumors (9), Breast Cancer (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hackensack?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hackensack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hackensack?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hackensack?
Recruiting research sites in Hackensack include Hackensack University Medical Center, John Theurer Cancer Center at Hackensack University Medical Center, John Theurer Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hackensack right now?
The largest active categories in Hackensack are Cancer & tumors (183), Neurology & pain (15), Cardiovascular (15). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.